![<description><p>In this episode, we explore a surprising new contender in the fight against alcohol use disorder — semaglutide. Could the blockbuster weight-loss drug also curb heavy drinking? We examine the first randomized controlled trial testing this GLP-1 receptor agonist specifically for AUD.</p> <p>Faculty: David A. Gorelick, M.D., Ph.D., D.L.F.A.P.A., F.A.S.A.M.<br /> Host: Richard Seeber, M.D.</p> <ul> <li><a href= "https://psychopharmacologyinstitute.com/cme-program?section=pricing&utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC444" target="_blank" rel="noopener"><strong>Learn more about our membership here</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/section/new-guidelines-for-clozapine-anc-monitoring/?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC444" target="_blank" rel="noopener"><strong>Earn 0.75 CMEs: Quick Take Vol. 79</strong></a></li> <li><a href= "https://psychopharmacologyinstitute.com/section/semaglutide-for-alcohol-use-disorder-new-rct-data/?utm_source=Podcast&utm_medium=Podcast&utm_campaign=[Libsyn]OPC444" target="_blank" rel="noopener"><strong>Semaglutide for Alcohol Use Disorder: New RCT Data</strong></a></li> </ul></description>](https://us-central1-podcastguru-217d6.cloudfunctions.net/gcf_get_image?image_url=https://is1-ssl.mzstatic.com/image/thumb/Podcasts113/v4/a9/69/49/a969490e-d250-e43b-39ed-9a8acc178615/mza_2271515149008366696.png/600x600bb.jpg&width=300&height=300&api_key=xqFmUFX5BHLBTA)
Psychopharmacology and Psychiatry Updates
Psychopharmacology Institute
Beyond Weight Loss: Can Semaglutide Treat Alcohol Use Disorder?
APR 1, 20268 MIN
Beyond Weight Loss: Can Semaglutide Treat Alcohol Use Disorder?
APR 1, 20268 MIN
Psychopharmacology Institute